This independent meeting is sponsored by pharmaceutical companies, who have had no influence over, or input into, the meeting agenda or content or selection of speakers, except in the sponsored symposia sessions. Sponsors will not be contributing in any way to any hospitality associated with the meeting. Click here for a list of sponsors.
Join us for our 20th Annual Scientific Meeting where the focus will be on how we can develop multidisciplinary team services in heart and kidney care to meet future needs. This popular one-day meeting will bring together an expert faculty and delegates across the cardiovascular, metabolic and renal teams. State-of-the-art presentations with interactive discussion and case-based learning will be offered, with time to network in the breaks and visit our exhibition.
Is it for me?
Our meetings are aimed at healthcare professionals and are aimed at anyone treating the cardiorenal patient particularly those working in heart failure, cardiology, nephrology, diabetes, lipids, endocrinology, care of the elderly, general medicine, general practice, clinical pharmacy and allied disciplines. Feedback from past delegates has been very positive with 100% of delegates at our last meeting saying the meeting was clinically excellent to good.
Accreditation
The Cardiorenal Forum will award 5 CPD credits for this meeting.
Academic endorsement
Last year’s meeting was endorsed by The British Society for Heart Failure (BSH), the Irish Nephrology Society, Kidney Disease Improving Global Outcomes (KDIGO), and the UK Kidney Association (UKKA), from whom we will be seeking academic endorsement for this year's meeting.
Registration fee
Our registration fees are subsidised. Early bird fees to include lunch and refreshments throughout the day will be:
£115 doctors (SpR and consultant grades), £80 concessions (nurses, trainees, allied HCPs), £300 commercial organisations. All fees are inclusive of VAT.
Travel grants
We will be offering a limited number of travel grants for the 2025 meeting to delegates qualifying for the concessions rate and living outside the M25 area.
09:25 | Introduction Chairs: Professor Paul Kalra, Consultant Cardiologist, Portsmouth Hospitals NHS Trust, Portsmouth & Professor Philip Kalra, Consultant Nephrologist, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust; Professor of Renal Medicine, University of Manchester |
09.30 | Future approaches to obesity and diabetes to reduce heart and kidney disease Dr Julia Kenkre, Consultant in Metabolic Medicine, Imperial College Healthcare NHS Trust, London |
09.50 | The effects of weight loss on cardiometabolic risk - and how to achieve it Dr Elizabeth Morris, General Practitioner and Wellcome Trust Clinical Research Fellow, Nuffield Department of Primary Care Health Sciences, University of Oxford |
10.10 | Discussion |
Chair: Dr Lisa Anderson, Heart Failure Consultant, St George’s University Hospital NHS Foundation Trust; Chair, British Society for Heart Failure | |
10:20 | Device therapy for patients with heart failure Dr Andrew Flett, Consultant Cardiologist, University Hospital Southampton NHS Foundation Trust |
10:40 | Sequencing the re-introduction of heart failure treatment pillars after AKI Ms Victoria Ruszala, Specialist Pharmacist in Cardiology and Heart Failure, North Bristol NHS Trust |
10.55 | Discussion |
11:00 | COFFEE BREAK / EXHIBITION AND NETWORKING |
Chair: Professor Gerry McCann, NIHR Research Professor, (Experimental Medicine) and Professor of Cardiac Imaging, University of Leicester | |
12:05 | Activity for longevity – truth and reconciliation Professor Thomas Yates, Professor in Physical Health and Activity, Leicester Lifestyle and Health Research Group, Diabetes Research Centre, University of Leicester |
12.25 | Discussion |
Chair: Dr David Lappin, Consultant Nephrologist, Galway University Hospitals; Honorary Personal Professor of Medicine, University of Galway | |
12:30 | Advances in preventing antibody-mediated graft rejection following organ transplantation Dr Ciara Magee, Consultant Nephrologist, Beaumont Hospital, Dublin |
12.55 | Discussion |
13:00 | LUNCH BREAK / EXHIBITION AND NETWORKING |
Chairs: Professor Smeeta Sinha, Consultant Nephrologist, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust; Professor of Renal Medicine, University of Manchester & Dr Matthew Graham-Brown, Associate Professor of Renal Medicine, University of Leicester; Honorary Consultant Nephrologist, University Hospitals of Leicester | |
14:40 | How a bespoke multi-morbidity clinic can improve management of people with metabolic-renal-cardiac-disease Dr Saif Al-Chalabi, Clinical Research Fellow, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust |
14:50 | Lessons from the metabolic-renal-cardiac clinic, e-referrals, and the virtual MDT Professor Darren Green, Consultant Nephrologist, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust; Professor of Cardiorenal Sciences, Manchester Metropolitan University; Honorary Professor of Medicine, University of Manchester |
15.10 | Discussion |
15:15 | TEA BREAK / EXHIBITION AND NETWORKING |
Chair: Ms Carys Barton, Heart Failure Nurse Consultant, Imperial NHS Foundation Trust, London; Chair-Elect, British Society for Heart Failure & Dr David Mulcahy, Consultant Cardiologist, Blackrock Health Hermitage Clinic, Dublin | |
15:40 | Cardiac trials Dr Geraint Morton, Consultant Cardiologist, Portsmouth Hospitals NHS Trust |
15:55 | Renal trials Dr David Lappin, Consultant Nephrologist, Galway University Hospitals; Honorary Personal Professor of Medicine, University of Galway |
16.10 | Discussion |
Chair: Dr Sarah Birkhoelzer, Cardiology Registrar, University Hospital Southampton NHS Foundation Trust | |
16:15 | Case 1: IgA nephropathy (IgAN) Dr Matthew Graham-Brown, Associate Professor of Renal Medicine, University of Leicester; Honorary Consultant Nephrologist, University Hospitals of Leicester |
16:30 | Case 2: Cardiac amyloid Ms Angelique Smit, Lead Clinical and Research Nurse, National Amyloidosis Centre, Royal Free London NHS Foundation Trust |
16:45 | Case 3: HIF-PHI Professor Philip Kalra, Consultant Nephrologist, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust; Professor of Renal Medicine, University of Manchester |
17:00 | Meeting close |
Dr Saif Al-Chalabi |
![]() |
|
Dr Lisa Anderson |
![]() |
|
Mrs Carys Barton |
![]() |
|
Dr Sarah Birkhoelzer |
![]() |
|
Dr Andrew Flett |
![]() |
|
Dr Matthew Graham-Brown |
![]() |
|
Professor Darren Green | ![]() |
|
Professor Paul Kalra |
![]() |
|
Professor Philip Kalra |
![]() |
Dr Julia Kenkre |
![]() |
|
Dr David Lappin |
![]() |
|
Dr Ciara Magee |
![]() |
|
Professor Gerry McCann |
![]() |
|
Dr Elizabeth Morris |
![]() |
|
Dr Geraint Morton |
![]() |
|
Dr David Mulcahy |
![]() |
|
Ms Victoria Ruszala |
![]() |
|
Professor Smeeta Sinha |
![]() |
|
Ms Angelique Smit Lead Clinical and Research Nurse, National Amyloidosis Centre, Royal Free London NHS Foundation Trust |
||
Professor Thomas Yates Professor in Physical Health and Activity, Leicester Lifestyle and Health Research Group, Diabetes Research Centre, University of Leicester |